Skip to main content

Peer Review reports

From: A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Original Submission
13 May 2014 Submitted Original manuscript
13 May 2014 Author responded Author comments - yun wang
Resubmission - Version 2
13 May 2014 Submitted Manuscript version 2
15 May 2014 Author responded Author comments - yun wang
Resubmission - Version 3
15 May 2014 Submitted Manuscript version 3
26 Jul 2014 Reviewed Reviewer Report - Andrew Clamp
3 Aug 2014 Reviewed Reviewer Report - Alain Zeimet
15 Oct 2014 Author responded Author comments - yun wang
Resubmission - Version 4
15 Oct 2014 Submitted Manuscript version 4
17 Nov 2014 Author responded Author comments - yun wang
Resubmission - Version 5
17 Nov 2014 Submitted Manuscript version 5
Publishing
20 Nov 2014 Editorially accepted
11 Dec 2014 Article published 10.1186/1471-2407-14-937

You can find further information about peer review here.

Back to article page